Rchr
J-GLOBAL ID：201801000094277416   Update date: Oct. 31, 2024

Yokoyama Yasuhisa

ヨコヤマ ヤスヒサ | Yokoyama Yasuhisa
Affiliation and department：
Center Hospital of the National Center for Global Health and Medicine Department of Transfusion Medicine and Cell Therapy

About Center Hospital of the National Center for Global Health and Medicine Department of Transfusion Medicine and Cell Therapy


Job title： Chief Physician
Research field  (1)： Hematology and oncology
Research theme for competitive and other funds  (7)：
  • 2021 - 2024 本邦における初発急性前骨髄球性白血病に対するATRA・ATO併用分化誘導療法の確立
  • 2018 - 2021 Analyses of hematopoietic niche in hematologic malignancy
  • 2015 - 2018 成人慢性好中球減少症の診療ガイドライン作成に向けた予後追跡調査
  • 2013 - 2015 Identification of unipotent megakaryocyte progenitor and analysis of megakaryopoietic pathway
  • 2011 - 2013 Establishment of evaluation method for double strand repair capacity with peripheral blood
Show all
Papers (138)：
  • Yasuhisa Yokoyama. Risk factors and remaining challenges in the treatment of acute promyelocytic leukemia. International Journal of Hematology. 2024
  • Yumiko Maruyama, Hidekazu Nishikii, Naoki Kurita, Tatsuhiro Sakamoto, Keiichiro Hattori, Yasuhito Suehara, Yasuhisa Yokoyama, Takayasu Kato, Naoshi Obara, Mamiko Sakata-Yanagimoto, et al. Impact of CD34 positive cell dose in donor graft on the outcomes after haploidentical peripheral blood stem cell transplantation with post-transplant cyclophosphamide - A retrospective single-center study with a Japanese cohort. Blood cells, molecules & diseases. 2024. 105. 102820-102820
  • Haruka Momose, Naoki Kurita, Hidekazu Nishikii, Nozomi Yusa, Kazuaki Yokoyama, Eigo Shimizu, Seiya Imoto, Toru Nanmoku, Yumiko Maruyama, Tatsuhiro Sakamoto, et al. [Durable remission of T-cell prolymphocytic leukemia with CLEC16A::IL2 after allogeneic hematopoietic stem cell transplantation]. [Rinsho ketsueki] The Japanese journal of clinical hematology. 2024. 65. 1. 35-40
  • Naoki Kurita, Hidekazu Nishikii, Yumiko Maruyama, Yasuhito Suehara, Keiichiro Hattori, Tatsuhiro Sakamoto, Takayasu Kato, Yasuhisa Yokoyama, Naoshi Obara, Kazushi Maruo, et al. Safety of romiplostim administered immediately after cord-blood transplantation: a phase 1 trial. Annals of Hematology. 2023
  • Tatsuhiro Sakamoto, Naoshi Obara, Yumiko Maruyama, Takayasu Kato, Naoki Kurita, Keiichiro Hattori, Yasuhito Suehara, Hidekazu Nishikii, Yasuhisa Yokoyama, Mamiko Sakata-Yanagimoto, et al. Repeated immunosuppressive rabbit antithymocyte globulin therapy for adult patients with relapsed or refractory aplastic anemia. European journal of haematology. 2023
ｍore...
MISC (14)：
  • 服部 圭一郎, 高野 晋吾, 坂田(柳元) 麻実子, 日下部 学, 野口 雅之, 横山 泰久, 加藤 貴康, 栗田 尚樹, 錦井 秀和, 小原 直, et al. Genetic evidence implies that primary and relapsed tumors arise from common precursor cells in primary central nervous system lymphoma. Cancer Science. 2018. 110. 1. 401-407
  • 小原 直, 加藤 貴康, 日下部 学, 錦井 秀和, 栗田 尚樹, 横山 泰久, 坂田(柳元) 麻実子, 長谷川 雄一, 千葉 滋, Kenichi Makishima, et al. High efficacy of eculizumab treatment for fulminant hemolytic anemia in primary cold agglutinin disease. Annals of hematology. 2018. 98. 4. 1031-1032
  • 横山泰久, 小原直, 五所正彦, 鈴木隆浩, 高見昭良, 宮崎泰司, 赤司浩一, 千葉滋. 成人慢性好中球減少症の予後追跡調査. 日本内科学会雑誌. 2018. 107. 臨増. 219-219
  • Hattori Keiichiro, Sakata-Yanagimoto Mamiko, Suehara Yasuhito, Yokoyama Yasuhisa, Kato Takayasu, Kurita Naoki, Nishikii Hidekazu, Obara Naoshi, Takano Shingo, Ishikawa Eiichi, et al. Clinical significance of disease-specific MYD88 mutations in circulating DNA in primary central nervous system lymphoma. Cancer science. 2018. 109. 1. 225-230
  • Primary chronic neutropenia in adults. 2016. 73. 4. 543-547
ｍore...
Books (34)：
  • HEMATOLOGY
    2024
  • Medical Syndrome of Blood Diseases 3rd edition (II)
    日本臨牀社 2023
  • 血液専門医テキスト 改訂第4版
    南江堂 2023 ISBN:9784524203710
  • 臨床雑誌 内科
    株式会社南江堂 2023
  • Practical Guidelines for Hematological Malignancies, 2023
    金原出版株式会社 2023 ISBN:9784307102247
ｍore...
Lectures and oral presentations  (64)：
  • BTK 阻害薬が著効した脳神経障害を有する再発難治 MYD88 変異陽性 B 細胞リンパ腫
    (第18回 日本血液学会関東甲信越地方会)
  • Temporal changes in ABO blood groups and clinical significance after ABO-incompatible HSCT
    (第45回 日本造血・免疫細胞療法学会総会)
  • 造血幹細胞移植患者におけるタクロリムスとレテルモビルの薬物相互作用:タクロリムスの投与経路が薬物相互作用に及ぼす影響
    (第48回日本臓器保存生物医学会学術集会)
  • Genetic subtypes of angioimmunoblastic T-cell lymphoma are associated with distinct outcomes
    (第84回日本血液学会学術集会)
  • Long-term observation of PNH type cells after immunosuppressive therapy for aplastic anemia
    (第84回日本血液学会学術集会)
ｍore...
Work history (1)：
  • 2024/04 - 現在 Center Hospital of the National Center for Global Health and Medicine Department of Transfusion Medicine and Cell Therapy Chief Physician
Association Membership(s) (5)：
The Japan Society of Transfusion Medicine and Cell Therapy ,  Japan Society for Hematopoietic Cell Transplantation ,  THE JAPANESE SOCIETY FOR REGENERATIVE MEDICINE ,  THE JAPANESE SOCIETY OF HEMATOLOGY ,  THE JANPANESE SOCIETY OF INTERNAL MEDICINE
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM